Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Joseph Golembiewski currently holds 86,869 shares of SEELOS THERAPEUTICS, INC. (SEEL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Joseph Golembiewski has been a net buyer of SEEL stock. They have purchased $100.4K and sold $0 worth of shares.
Michael Joseph Golembiewski's most recent insider trade was on Feb 29, 2024, when they sold 417 shares at $1.10 per share.
Michael Joseph Golembiewski serves as Executive at SEELOS THERAPEUTICS, INC. (SEEL). They have executed 7 insider transactions totaling $100.4K over their tenure at the company.
Michael Joseph Golembiewski holds the position of Executive at SEELOS THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Michael Joseph Golembiewski has shown a buying trading pattern, with $100.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael Joseph Golembiewski was on Nov 30, 2023, when they purchased $100.4K worth of SEEL shares. This transaction involved 83,000 shares at $1.21 per share.
Michael Joseph Golembiewski currently owns 86,869 shares of SEELOS THERAPEUTICS, INC. (SEEL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Joseph Golembiewski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Joseph Golembiewski has 7 Form 4 filings on record as an insider at SEELOS THERAPEUTICS, INC..
Set alerts for Michael Joseph Golembiewski and 40,000+ other insiders.